MichaelAGaroneMDFACG

Inflammatory Bowel Disease

Gastroenterologist at Gastro Health Virginia Specializing in IBD Assistant Clinical Professor of Medicine, George Washington University Hospital

Dr. Garone is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3700 Joseph Siewick Dr
308
Fairfax, VA 22033
Phone+1 703-698-8960

Fax+1 703-828-0961

Top Doctors Washingtonian Magazine, 1992-2019
Top Doctors:Washington DC Area Castle Connolly, 2016
Top Doctors:Washington-Baltimore Castle Connolly, 2016
Top Doctors Northern Virginia Magazine, 2016
CMS Meaningful Use Stage 1 Certification Centricity Practice Solution EMR, GE Healthcare, 2011-2013
Physician Recognition Award American Medical Association
Top Doctors U.S. News and World Report
Top Doctors Castle Connolly
Top Doctors Checkbook Magazine
Top Doctors Super Doctors
Top Doctors Angie’s List
Fellow American College of Gastroenterology
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Join now to see all

PubMed

1 citations
Guidance for Healthcare Providers on Newest Guidelines for Over-the-Counter Drug Treatment of Mild Symptoms of COVID-19.
Gage Collamore, Mark J DiCorcia, Yash Nagpal, Lawrence Fiedler, Michael A Garone
The American Journal of Medicine. 2024-06-01
26 citations
Metabolic syndrome after laparoscopic bariatric surgery.
Clare Nugent, Chunhong Bai, Hazem Elariny, Priya Gopalakrishnan, Caitlin Quigley
Obesity Surgery. 2008-04-09
22 citations
A multicenter retrospective experience of infliximab in Crohn's disease patients: infusion reaction rates and treatment persistency.
Ali Keshavarzian, Lloyd Mayer, Bruce Salzberg, Michael Garone, Warren Finkelstein
Gastroenterology & Hepatology. 2007-05-01

Journal Articles

A multicenter retrospective experience of infliximab in Crohn’s disease patients: infusion reaction rates and treatment persistency
Keshavarzian A, Mayer L, Salzberg B, Garone M, Finkelstein W, Cappa J, Brand M, Hain J, Zelinger D, Hegedus R, Diamond RH, Campbell U, Lane C, Stang P, Watson J, Comin..., Gastroenterol Hepatol, 1/1/2007